Kari Mergens, | |
13402 Jefferson St, Becker, MN 55308-4602 | |
(763) 689-5385 | |
Not Available |
Full Name | Kari Mergens |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 13402 Jefferson St, Becker, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679911093 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Kari Mergens, 13402 Jefferson St, Becker, MN 55308-4602 Ph: () - | Kari Mergens, 13402 Jefferson St, Becker, MN 55308-4602 Ph: (763) 689-5385 |
News Archive
Mount Sinai researchers are the first in the country to use artificial intelligence (AI) combined with imaging, and clinical data to analyze patients with coronavirus disease (COVID-19).
Men who have a history of delinquency in childhood are more likely to die or become disabled by the time they are 48, and not just from the obvious consequences of antisocial behaviour, new research indicates.
Dendreon Corporation today reported results for the year and quarter ended December 31, 2011. Product revenue for the year ended December 31, 2011 was $213.5 million compared to $48 million for the year ended December 31, 2010. Product revenue for the fourth quarter of 2011 was $77 million compared to $25 million for the quarter ended December 31, 2010.
Nearly 2 million adults in California, about 8 percent of the population, need mental health treatment, but the majority receive no services or inadequate services, despite a state law mandating that health insurance providers include mental health treatment in their coverage options, a new report by the UCLA Center for Health Policy Research shows.
Scientists have identified a surprising new role for a new type of T cell in the immune system: some of them can be activated by nerves to make a neurotransmitter (acetylcholine) that blocks inflammation. The discovery of these T cells is novel and suggests that it may be possible to treat inflammation and autoimmune diseases by targeting the nerves and the T cells. The study was published this week in Science.
› Verified 1 days ago